Exane BNP Paribas initiated coverage on Brown-Forman with a new price target
$BF.B
Exane BNP Paribas initiated coverage of Brown-Forman with a rating of Outperform and set a new price target of $48.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/25/2024 | $48.00 | Outperform | Exane BNP Paribas |
| 11/6/2024 | $50.00 → $48.00 | Buy → Hold | TD Cowen |
| 9/30/2024 | $43.00 → $53.00 | Equal Weight → Overweight | Barclays |
| 4/2/2024 | $52.00 | Sell → Neutral | Citigroup |
| 1/29/2024 | $68.00 → $58.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/11/2023 | $73.00 → $76.40 | Mkt Perform → Outperform | Bernstein |
| 8/31/2023 | $66.00 → $69.00 | Neutral | ROTH MKM |
| 8/23/2023 | $66.00 → $75.00 | Underweight → Overweight | Morgan Stanley |
10-Q - BROWN FORMAN CORP (0000014693) (Filer)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
Exane BNP Paribas initiated coverage of Brown-Forman with a rating of Outperform and set a new price target of $48.00
TD Cowen downgraded Brown-Forman from Buy to Hold and set a new price target of $48.00 from $50.00 previously
Barclays upgraded Brown-Forman from Equal Weight to Overweight and set a new price target of $53.00 from $43.00 previously
4 - BROWN FORMAN CORP (0000014693) (Issuer)
3/A - BROWN FORMAN CORP (0000014693) (Issuer)
4 - BROWN FORMAN CORP (0000014693) (Issuer)
Brown-Forman Corp (NYSE: BF-B) (NYSE: BF-A) reported first-quarter FY24 sales growth of 3% year-on-year to $1.04 billion, missing the analyst consensus of $1.05 billion. EPS of $0.48 missed the analyst consensus of $0.53. The gross margin expanded 100 basis points Y/Y to 62.7%. The operating margin contracted 250 basis points to 31.5%, and operating income for the quarter fell 4% to $327 million. The company held $426 million in cash and equivalents as of July 31, 2023. Cash provided by operating activities totaled $38 million. "As anticipated, our first quarter growth was impacted by the difficult shipment comparison from fiscal 2023, when we rebuilt inventory impacted by prior glass su
The U.S. Supreme Court heard arguments in a trademark clash between Brown-Forman Corp (NYSE: BF-B) owned Jack Daniel's and a dog accessory company. The case is about a parody chew toy that resembles the distiller's black-label whiskey bottle, reported Reuters. This is a case of Jack Daniel's trademark rights against legal protections for creative expression by VIP Products LLC. The report added that Jack Daniel's Properties Inc had appealed a lower court's ruling that VIP's vinyl chew toy qualifies as an "expressive work" protected by the U.S. Constitution's First Amendment. Industry groups that support the Tennessee-based whiskey brand, say the dispute is important for corporate Ameri
Wedbush analyst Gerald Pascarelli initiates coverage on Brown-Forman (BATS:BF) with a Neutral rating and announces Price Target of $70.